Newsletter Signup
Where current and emerging technology trends meet.
TecTrendsInformation Sources, Inc.
  | About TecTrends | Email Signup | Contact Us
 Live Search:
Live Search | Articles | Companies | TecTerms | Products
  Loading TecTrends Live Search - please wait... 
View Noteworthy Articles      PRNewswire
 
Company

NanoViricides Inc Products   
135 Wood St #205
West Haven,  CT  06516
United States
URL: http://www.nanoviricides.com
Email: info@nanoviricides.com

NanoViricides Incorporated develops targeted anti-viral therapeutics that employ nanoscale materials. The company's nanoviricide (TM) drug products are used to treat a variety of human and animal viruses. The firm's nanoviricide products are a few billionths of a meter in size. The treatments are used to reduce virus circulating in the bloodstream. Each nanoviricide is targeted to a particular virus or group of viruses. NanoViricides is developing treatments that prevent virus particles from infecting new cells, that dismantle virus particles, and that destroy genetic material associated with viruses. The company's FluCide-I (TM) will be used to treat human influenza. HepaCide-I (TM) will treat Hepatitis C. RabiCide-I (TM) will treat the rabies virus. NanoViricides also is developing treatments for HIV, avian influenza, and highly pathogenic influenzas. Clinical studies for the company's drug candidates begin in 2007. NanoViricides licenses materials and processes from TheraCour Pharma Incorporated.

Org. Type: Corporation Equity Type: Public
Company Status: Active
Symbol: OTC:NNVC.PK

Products:
NanoViricides Inc--Company News

TecTerms:
 


Home About TecTrends About Us Contact Us Privacy Statement Terms and Conditions

TecTrends | P.O. Box 8120 | Berkeley CA 94707 | (510) 525-6220 | Email: tectrends@tectrends.com
© 2006 INFORMATION SOURCES INC | All rights reserved.